# Sprott Physical Gold Trust: financial statements, quarterly

PHYS · NYSE · CIK 1477049 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/phys.md) · [Financials](/companies/phys/financials.md) · [Filings](/companies/phys/filings.md) · [Insiders](/companies/phys/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/phys/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001558370-18-002503.md) | [0.0](/filings/0001558370-19-002634.md) | [0.0](/filings/0001558370-20-003395.md) | [0.0](/filings/0001558370-21-003328.md) | [0.0](/filings/0001387131-22-003802.md) | [0.0](/filings/0001387131-23-003843.md) | [0.0](/filings/0001999371-24-003926.md) | [0.0](/filings/0001999371-25-002923.md) | [0.0](/filings/0001999371-26-005820.md) | [0.0](/filings/0001999371-26-005820.md) | [0.0](/filings/0001999371-26-005820.md) |
| Total assets | $bn | not reported | [2.1](/filings/0001558370-18-002503.md) | [2.3](/filings/0001558370-19-002634.md) | [2.0](/filings/0001558370-20-003395.md) | [2.5](/filings/0001558370-21-003328.md) | [4.9](/filings/0001387131-22-003802.md) | [5.0](/filings/0001387131-23-003843.md) | [5.7](/filings/0001999371-24-003926.md) | [6.5](/filings/0001999371-25-002923.md) | [8.6](/filings/0001999371-26-005820.md) | [16.0](/filings/0001999371-26-005820.md) |
| Total liabilities | $bn | not reported | [0.0](/filings/0001558370-18-002503.md) | [0.0](/filings/0001558370-19-002634.md) | [0.0](/filings/0001558370-20-003395.md) | [0.0](/filings/0001558370-21-003328.md) | [0.0](/filings/0001387131-22-003802.md) | [0.0](/filings/0001387131-23-003843.md) | [0.0](/filings/0001999371-24-003926.md) | [0.0](/filings/0001999371-25-002923.md) | [0.0](/filings/0001999371-26-005820.md) | [0.0](/filings/0001999371-26-005820.md) |
| Shareholders' equity | $bn | [1.2](/filings/0001558370-18-002503.md) | [2.1](/filings/0001558370-19-002634.md) | [2.3](/filings/0001558370-20-003395.md) | [2.0](/filings/0001558370-21-003328.md) | [2.5](/filings/0001387131-22-003802.md) | [4.9](/filings/0001387131-23-003843.md) | [5.0](/filings/0001999371-24-003926.md) | [5.7](/filings/0001999371-25-002923.md) | [6.5](/filings/0001999371-26-005820.md) | [8.6](/filings/0001999371-26-005820.md) | [16.0](/filings/0001999371-26-005820.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 475,484,857 at 2025-12-31, from the cover of the [40-F filed 2026-03-13](/filings/0001999371-26-005820.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.